On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent ...

WASHINGTON (AP) - A disappearing medical implant will get a closer look from the Food and Drug Administration this week. The FDA meets on Tuesday to review Abbott Laboratories' first-of-a-kind heart ...

WASHINGTON – A medical implant that slowly dissolves into the body could be the answer to long-standing safety concerns with devices used to treat clogged arteries. But not so fast, say experts.

The FINANCIAL — Abbott announced on July 5 that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device ...

Now you see it, now you don't. A new type of heart stent that works like dissolving stitches, slowly going away after it has done its job, passed its first major test in a large study, doctors said ...

The Food and Drug Administration is warning clinicians that patients implanted with Abbott Laboratories’ Absorb dissolving stent may experience more heart issues than those implanted with the ...

Cardiologists have implanted Chicago-based Abbott Laboratories’ new dissolving heart stent into the first patients, according to The Wall Street Journal. The biodegradable stent, called Absorb, was ...

Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new ...

CONCORD, Calif. (KGO) -- Research being conducted here in the Bay Area could provide a major advance for heart patients. Surgeons at John Muir Medical Center in Concord are implanting patients with a ...

WASHINGTON, DC — Patients who received the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) in the ABSORB-3 trial showed a primary outcome, counting only events occurring between the ...